Item 9 Labs(INLB)
$0.000.00 (0.00%)
INLB
Item 9 Labs financials statements
$0.00
At close:0.00 (0.00%)
Item 9 Labs (INLB) Ratios
27 Followers
Item 9 Labs Ratios
INLB's free cash flow for Q3 2023 was $87.29K. For the 2023 fiscal year, INLB's free cash flow was decreased by $-62.84K and operating cash flow was $150.14K. See a summary of the company’s cash flow.
| Ratios | Dec 22 | Dec 21 | Dec 20 | Dec 19 | Sep 18 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.09 | 0.71 | 0.28 | 0.42 | 1.93 |
| Quick Ratio | 0.03 | 0.28 | 0.07 | 0.39 | 1.93 |
| Cash Ratio | 0.00 | 0.10 | 0.01 | 0.00 | 0.19 |
| Solvency Ratio | -0.60 | -0.31 | -0.90 | -1.39 | -0.66 |
| Operating Cash Flow Ratio | -0.06 | -0.40 | -0.11 | -0.34 | -1.09 |
| Short-Term Operating Cash Flow Coverage | -0.11 | -1.02 | -0.21 | -0.50 | -39.03 |
| Net Current Asset Value | $ -45.27M | $ -20.11M | $ -9.76M | $ -4.17M | $ 834.38K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.25 | 0.18 | 0.38 | 0.33 | 0.01 |
| Debt-to-Equity Ratio | 0.45 | 0.24 | 0.99 | 0.64 | 0.01 |
| Debt-to-Capital Ratio | 0.31 | 0.20 | 0.50 | 0.39 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.10 | 0.15 | 0.22 | 0.00 | 0.36 |
| Financial Leverage Ratio | 1.79 | 1.36 | 2.58 | 1.94 | 1.34 |
| Debt Service Coverage Ratio | -0.88 | -0.39 | -0.35 | -1.88 | -23.49 |
| Interest Coverage Ratio | -3.60 | -1.06 | -0.77 | -12.79 | -347.63 |
| Debt to Market Cap | 0.71 | 0.17 | 0.08 | 0.03 | 5.06 |
| Interest Debt Per Share | 0.36 | 0.33 | 0.24 | 0.08 | 0.01 |
| Net Debt to EBITDA | -1.22 | -4.48 | -1.77 | -0.53 | 0.25 |
| Profitability Margins | |||||
| Gross Profit Margin | 33.61% | 39.26% | 40.58% | 48.19% | 25.97% |
| EBIT Margin | -113.76% | -25.57% | -66.81% | -194.69% | -48.10% |
| EBITDA Margin | -104.93% | -19.83% | -54.75% | -180.99% | -43.92% |
| Operating Profit Margin | -106.01% | -25.53% | -65.58% | -88.82% | -50.28% |
| Pretax Profit Margin | -143.25% | -49.71% | -152.50% | -201.64% | -48.25% |
| Net Profit Margin | -143.14% | -49.71% | -151.44% | -215.47% | -46.70% |
| Continuous Operations Profit Margin | -143.31% | -49.71% | -151.44% | -201.64% | -48.25% |
| Net Income Per EBT | 99.93% | 100.00% | 99.31% | 106.86% | 96.79% |
| EBT Per EBIT | 135.12% | 194.70% | 232.55% | 227.02% | 95.97% |
| Return on Assets (ROA) | -28.12% | -9.34% | -59.52% | -73.45% | -18.28% |
| Return on Equity (ROE) | -50.26% | -12.67% | -153.45% | -142.50% | -24.54% |
| Return on Capital Employed (ROCE) | -32.87% | -5.50% | -51.33% | -59.73% | -26.42% |
| Return on Invested Capital (ROIC) | -25.59% | -5.20% | -33.14% | -36.19% | -26.17% |
| Return on Tangible Assets | -76.35% | -27.21% | -104.39% | -92.30% | -18.28% |
| Earnings Yield | -82.39% | -8.73% | -13.31% | -6.19% | -213.23% |
| Efficiency Ratios | |||||
| Receivables Turnover | 37.11 | 15.15 | 23.03 | 11.29 | 1.43 |
| Payables Turnover | 2.25 | 3.54 | 2.44 | 2.37 | 1.41 |
| Inventory Turnover | 5.86 | 2.08 | 2.25 | 14.20 | 0.00 |
| Fixed Asset Turnover | 0.99 | 1.89 | 0.94 | 0.63 | 0.96 |
| Asset Turnover | 0.20 | 0.19 | 0.39 | 0.34 | 0.39 |
| Working Capital Turnover Ratio | -1.05 | -3.72 | -1.40 | -2.95 | -1.97 |
| Cash Conversion Cycle | -90.17 | 96.18 | 28.70 | -95.69 | -3.14 |
| Days of Sales Outstanding | 9.84 | 24.10 | 15.85 | 32.33 | 255.17 |
| Days of Inventory Outstanding | 62.27 | 175.08 | 162.39 | 25.70 | 0.00 |
| Days of Payables Outstanding | 162.27 | 102.99 | 149.54 | 153.72 | 258.31 |
| Operating Cycle | 72.10 | 199.18 | 178.24 | 58.03 | 255.17 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.02 | -0.08 | -0.02 | -0.04 | -0.36 |
| Free Cash Flow Per Share | -0.08 | -0.10 | -0.03 | -0.14 | -0.55 |
| Dividend Paid and CapEx Coverage Ratio | -0.41 | -2.67 | -2.81 | -0.37 | -1.80 |
| Capital Expenditure Coverage Ratio | -0.41 | -2.67 | -2.81 | -0.37 | -1.80 |
| Operating Cash Flow Coverage Ratio | -0.08 | -0.29 | -0.14 | -0.50 | -39.03 |
| Operating Cash Flow to Sales Ratio | -0.10 | -0.27 | -0.14 | -0.49 | -0.71 |
| Free Cash Flow Yield | -20.41% | -6.59% | -1.67% | -5.16% | -504.09% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.21 | -11.46 | -7.52 | -16.15 | -0.47 |
| Price-to-Sales (P/S) Ratio | 1.74 | 5.70 | 11.38 | 34.79 | 0.22 |
| Price-to-Book (P/B) Ratio | 0.61 | 1.45 | 11.53 | 23.01 | 0.12 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.90 | -15.18 | -59.73 | -19.40 | -0.20 |
| Price-to-Operating Cash Flow Ratio | -16.77 | -20.86 | -80.98 | -71.73 | -0.31 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 0.38 | -0.43 | 0.62 | -0.00 |
| Enterprise Value Multiple | -2.87 | -33.21 | -22.55 | -19.76 | -0.25 |
| Enterprise Value | 65.56M | 144.44M | 100.29M | 176.42M | 151.95K |
| EV to EBITDA | -2.87 | -33.21 | -22.55 | -19.76 | -0.25 |
| EV to Sales | 3.01 | 6.58 | 12.35 | 35.76 | 0.11 |
| EV to Free Cash Flow | -8.50 | -17.55 | -64.81 | -19.93 | -0.10 |
| EV to Operating Cash Flow | -29.08 | -24.12 | -87.87 | -73.71 | -0.16 |
| Tangible Book Value Per Share | -0.08 | 0.12 | -0.01 | 0.07 | 0.96 |
| Shareholders’ Equity Per Share | 0.65 | 1.10 | 0.13 | 0.12 | 0.96 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | 0.00 | 0.01 | -0.07 | -0.04 |
| Revenue Per Share | 0.23 | 0.28 | 0.13 | 0.08 | 0.50 |
| Net Income Per Share | -0.33 | -0.14 | -0.20 | -0.17 | -0.23 |
| Tax Burden | 1.00 | 1.00 | 0.99 | 1.07 | 0.97 |
| Interest Burden | 1.26 | 1.94 | 2.28 | 1.04 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.78 | 0.45 | 0.68 | 0.83 | 0.29 |
| Stock-Based Compensation to Revenue | 0.14 | 0.08 | 0.04 | 0.05 | 0.08 |
| Income Quality | 0.07 | 0.55 | 0.09 | 0.24 | 1.52 |
Currency in USD

